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j  chain expression in lymphoid cells has been detected by a  variety of immu- 
nochemical  techniques  (for reviews see  1-4).  Studies of mouse plasmacytomas 
initially suggested that J  chain  was synthesized only in cell lines that  produced 
polymeric  immunoglobulins  (5,  6).  This  result  supported  the  idea  of J  chain 
involvement in the process ofimmunoglobulin polymerization (2, 7, 8). However, 
subsequent studies have revealed that J  chain  may also be present in cells that 
contain  monomeric immunoglobulins,  heavy chains,  light chains,  or no immu- 
noglobulin  chains  (3,  4,  9-15).  The  latter  finding  is  particularly  intriguing 
because it suggests that J  chain  expression may occur independently of immu- 
noglobulin synthesis. 
With respect to B cell maturation,  Mather et al.  (16) concluded that J  chain 
synthesis  is  initiated  during  the  switch  from  synthesis  of membrane  IgM  to 
secretory IgM. In these studies of mouse lymphoid cells, early B cells and splenic 
lymphocytes contained little or no J  chain or J  chain-specific mRNA.  In studies 
of human lymphoblastoid cell lines, however, McCune et al. (17) detectedJ chain 
in  immunogiobulin-secreting,  B  cell,  and  pre-B  cell  lines.  These  variances 
prompted our studies of the morphological and biochemical correlation of  J and 
chain expression as a  function of differentiation along the human  B cell axis 
(18-22). 
Materials and Methods 
Cells.  Cells from peripheral blood (PB)  I and bone marrow (BM) of normal individuals, 
patients  with acute lymphocytic leukemia (ALL), two patients  with Sezary syndrome, and 
a  patient  with  acute myelofibrosis,  and  two pre-B  cell  lines (Nos.  207 and  697)  were 
examined.  Lymphoid cells from PB were separated by centrifugation on Ficoil-Hypaque 
gradients.  Immunologic characterization  of the leukemic cells was performed by immu- 
nofluorescence to  detect  surface and  cytoplasmic  immunoglobulin,  HLA-DR,  B  cell, 
common ALL, and a myelomonocytic antigen.  T  cells were enumerated by an E-rosette 
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assay. The methods used in determining the cell phenotypes are described elsewhere (23). 
Lymphocytes (106  cells/ml) from  PB of normal  individuals  were also  stimulated  with 
pokeweed mitogen (PWM) (10 #l/ml) and the presence of  J chain was determined on days 
0, 2, 5, and 8 of culture. 
In a previous study of J  chain biosynthesis (24), we used human lymphoblastoid cell 
lines that secrete IgG, IgA, or IgM and contain intracellular J chain to establish optimal 
conditions for the detection of J  chain in cell lysates by radioimmunoassay (RIA). To 
release intracellular contents, single-cell  suspensions were washed three times in phos- 
phate-buffered saline with 1% fetal bovine serum, adjusted to 107 cells/ml and disrupted 
by sonication at 0°C  for  1 min at  20 kHz/sec at 90  W  (Sonifer cell  disruptor, model 
W140; Health Systems-Ultrasonics, Inc., Plainview, NY). The sonicates were centrifuged 
for 5 min at 12,800 g and assayed directly for J chain; another aliquot was reduced (with 
10 mM dithiothreitol in 0.2 M Tris, pH 8.4, for 2 h at room temperature) and alkylated 
(with 21 mM iodoacetamide in 0.2 M Tris, pH 8.4, for 15 min) before theJ chain RIA. 
Lysates of human T  cell lines (MOLT-4, MOLT-3, and HSB), and an epithelial cell line 
from a human colonic carcinoma (HT-29) did not contain detectable J  chain and were 
used as controls (24). 
Antisera, RIA, and Immunohistochemistry.  Rabbit antibodies specific for either human # 
orJ chains were prepared by immunization with IgM-h protein purified from plasma of a 
patient with Waldenstr6m's macroglobulinemia, or with J  chain isolated by a previously 
described procedure (25) from S-sulfonated polymeric IgA2-h myeloma protein. The anti- 
IgM antibody was subsequently absorbed with IgG-~ myeloma protein and Bence-Jones 
chains covalently bound to cyanogen bromide-activated Sepharose 4B. The specificity of 
these reagents was tested by immunoelectrophoresis, immunofluorescence, and RIA (24, 
26). The details of the RIA forJ chain produced by human lymphoid cells were described 
previously (24). The sensitivity and range of  J  chain RIA was 0.2-25 ng]100 #1 sample. 
This anti-J chain reagent was also used by McCune et al. (17) for the immunoprecipitation 
of [3~S]methionine-labeled polypeptides produced in vitro and in vivo, and was found to 
selectively precipitate J chain. 
For immunohistochemical studies, Fab' and F(ab')2 fragments of anti-# and anti-J chain 
antibodies were labeled with  horseradish peroxidase (HRP) (type VI; Sigma Chemical 
Co., Saint Louis, MO) according to the method of Nakane and Kawaoi (27). For detection 
of intracellular J and # chains, cells were fixed with 3% glutaraldehyde in 0.2 M sodium 
cacodylate buffer, pH 7.35, for 30 min and treated with saponin (28). Cells were incubated 
subsequently with HRP-labeled Fab' or F(ab')2 fragments for 1 h at room temperature, 
washed with sodium cacodylate buffer, and reacted with 3,3'-diaminobenzidine tetrahy- 
drochloride (DAB) (Sigma Chemical Co.) to demonstrate peroxidase activity (29).  After 
the DAB reaction, the cell suspensions were fixed with  1% osmium tetroxide for 1 h, 
dehydrated with a graded ethanol and acetone series, and embedded in Spurr low viscosity 
resin (Ladd Research Industries, Inc., Burlington, VT). Thin sections were made with a 
ultramicrotome (Ultrotome III; LKB Instruments, Inc., Gaithersburg, MD) and examined, 
without counterstaining, in a Philips 300 electron microscope (TEM 300; Philips North 
America, Atlanta, GA). At least 600 cells from each preparation were examined. 
In control experiments, cells from (a) PB and BM of normal individuals, (b) patients 
with ALL, Sezary syndrome, and acute myelofibrosis, and (c) leukemic cell lines were 
examined for the presence of endogenous peroxidase by the  DAB reaction. Negative 
immunohistochemical controls included incubation of cells with DAB without hydrogen 
peroxide, incubation with heat-inactivated labeled antibodies, and incubation with HRP- 
labeled F(ab')2 fragments of the anti-a chain reagent. 
Results 
Presence of J  Chain in Leukemic Cells Representative of Early B Lineage Stages of 
Differentiation.  For the purpose of these studies,  highly enriched preparations 
of cells representative of early stages in differentiation along the B cell pathway 
were required.  Since it has not yet been possible to isolate precursor cells of B HAJDU  ET  AL.  1995 
lineage from normal tissues, representatives of their malignant counterparts were 
selected for study.  A  very early  stage  in  differentiation  along the  B  cell axis 
would involve rearrangements of the immunoglobulin heavy chain genes,  VH, 
D., and JH that precede # chain expression. Almost all leukemias of "null" (non- 
T,  non-B)  phenotype  have  features  suggestive  of an  arrest  at  this  stage  in 
differentiation in that they have nonproductive rearrangements of heavy chain 
genes, with or without rearranged light chain genes (30, 31), and express B cell 
differentiation antigens on their surface (32,  33).  For this study, four patients 
whose lymphocytes displayed null cell leukemic phenotype were selected. Pre-B 
leukemia cells represent the  next stage  in differentiation.  These cells express 
heavy chains but usually not light chains (34,  35).  We selected for study three 
representatives of this leukemic phenotype, all of which contained #  chains in 
their cytoplasm.  None of these expressed  light chains,  but one population of 
leukemic cells bore trace amounts of/z chain on the surface, and may therefore 
represent  a  pre-B/B  transitional  phase.  In  addition,  two  well-defined  pre-B 
leukemic cell lines (23, 36) were studied. 
Intracellular J  chain was  detected in  leukemic cells of both  null and pre-B 
phenotypes (Table I). In HLA-DR ÷ null cells, J  chain was detected in small and 
medium lymphocytes (7-9 #m); the majority of  J chain-positive cells of BM origin 
were  small  lymphocytes,  and  those  from  blood  samples  were  medium-sized 
lymphocytes (Fig.  1). J  chain was associated with ribosomes of the leukemic cells 
from both tissues. However, among J  chain-positive leukemic lymphocytes from 
BM, a  small subpopulation ("-,7%) expressed J  chain only on ribosomes bound 
to  the  membranes  of  the  perinuclear  cisternae  (Fig.  1D).  The  presence  of 
intracellular tt chain was detectable in <1%  of cells in the HLA-DR  + null cell 
preparations. 
In pre-B leukemic cells, J chain was detected on ribosomes distributed diffusely 
TABLE  I 
Presence of  J  Chain in Cells from Patients with ALL and in Pre-B Cell Lines 
Leukemic  cells  Source 
Percent  of cells positive for: 
Amount of  J 
chain (ng/10  ~ 
cells) 
Cyto-  Myelo-  Common 
HLA-DR  Surface  plasmic  B cell  mono-  ALL  E-rosette  J  Total*  Free 
ta chain  ~ chain  antigen  cytic  formation  chain* 
antigen  antigen 
ALL-Null  PB  >90  <1  <1  <1  <1  >90  5  88  20.0  6.7 
ALL-Null  BM  98  <1  <1  <1  2  98  <1  24  34.5  12,5 
PB  51  5  NDi  7  10  40  21  54  ND  ND 
ALL-Null  BM  100  <1  <1  ND  3  ND  <1  60  8.8  1.5 
ALL-Pre-B  BM  42  <1  83  <1  1  >90  <1  21  26.2  12.5 
PB  34  6  97  3  2  75  <1  2  ND  ND 
ALL-Pre-B  PB  >90  ND  67  12  ND  >90  ND  27  13.5  6.2 
ALL-Pre-B/B  PB  ND  84  82  ND  ND  ND  ND  80  12.5  7.8 
Pre-B  Cell line  80  <1  95  5  <1  70  <1  401  0,8  0.0 
207 
Pre-B  Cell line  47  <1  87  1  <1  70  <1  491  6.5  4.2 
697 
* By electron microscopy. 
* Reduced and alkylated  sample analyzed  by RIA. 
! Not determined. 
I Average values of five examinations (cell line 207: range 36-44 percent;  cell line 697: range 43-58 percent). FIGURE  1.  Subcellular distribution of J  chain in HLA-DR-positive null leukemia cells.  (A)J 
chain was detected on free ribosomes in medium-sized PBL. The cell in the upper left corner 
is J  chain  negative,  x  11,000.  (B) J  chain-positive small lymphocyte from  BM of the same 
patient, x  6,700. (C) Medium-sized lymphocyte from BM displays J  chain on free ribosomes 
but the Golgi apparatus in shallow nuclear indentation isJ chain negative, x  10,300. (D) Detail 
of two J  chain-positive cells.  The upper cell exhibits  J  chain only on ribosomes attached to the 
perinuclear cisterna (arrows);  the  lower  cell  contains J  chain  bound  to  free  ribosomes,  x 
19,600. 
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FIGURE 2.  Subcellular distribution of J  chain in  leukemic pre-B  cells.  (A)  Medium-sized 
lymphocyte (L) from peripheral blood containsJ chain on free ribosomes. The plasma cell (P) 
in the field contains J  chain, which is located primarily within Golgi-derived vesicles  (g).  x 
15,900.  (B)  Pre-B cell from  leukemic cell line 207.  Cytoplasm of the upper cell contains J 
chain-positive ribosomal clusters, x  16,300. (C) Pre-B/B leukemic cell is J  chain positive on 
free ribosomes, whereas numerous short profiles of RER areJ chain negative, x  8,500. 1998  EXPRESSION OF # ANDJ CHAIN IN B CELL DIFFERENTIATION 
in the cytoplasm of small lymphocytes (7-8 #m) (Fig. 2A) or on ribosomal clusters 
and  polysomes  of large  lymphoblasts  (10-13  ~m)  (Fig.  2B).  Mu  chain  was 
regularly found on free ribosomes and ribosomal clusters in both small and large 
pre-B cells. In leukemic pre-B cell lines, ~ chain was often detected in tubules of 
rough endoplasmic reticulum (RER)  of large dividing cells (Fig.  3,  C and D). 
The Golgi apparatus of large cells also contained t~ chain in vesicles of variable 
size (Fig. 3E). 
Subcellular Distribution of J  and  t~ Chains in PWM-stimulated  Lymphocytes from 
Normal Individuals.  Normal peripheral blood mononuclear cells were examined 
for the presence of  J and/~ chains, before and 2, 5, and 8 d after PWM stimulation 
(Table II). Increase in the numbers of cells expressing cytoplasmic J chain and u 
chain was observed as a function of time after PWM stimulation. J chain-positive 
cells were sixfold more numerous than # chain-positive cells at each time point 
examined. The increased proportions of  J chain-positive cells was due to the fact 
that J  chain was detectable in lymphocytes and lymphoblasts, whereas intracyto- 
plasmic ~  chain was primarily seen in  immature and mature plasma cells.  In 
addition, ~ and J  chains displayed different subcellular localization. In lympho- 
cytic cells, J  chain was detectable exclusively on free ribosomes and ribosomal 
clusters, and not in the Golgi apparatus or RER, when the latter organelle was 
present. In plasma cells, J chain was seen in RER or the Golgi apparatus, and not 
on free cytoplasmic ribosomes. The simultaneous presence of J  chain in  RER 
and in  the Golgi apparatus  was seen only occasionally (Fig.  4).  In contrast, # 
chain was regularly found in both RER and the Golgi apparatus of plasma cells 
on days 5 and 8 (Fig. 5). 
Only  0.3  and  3.7%  of the mononuclear cells isolated  from the  PB  of two 
patients with Sezary syndrome contained J chain; 2.5% of the BM cells from the 
latter patient  contained J  chain.  BM  from a  patient  with acute  myelofibrosis 
contained 0.4% J  chain-positive cells. 
Biosynthesis of  J Chain.  The levels of  J  chain present in lysates of null and pre- 
B ALL cells, two pre-B cell lines, and PWM-stimulated PB lympocytes (PBL) are 
presented in Tables I and II. J  chain was detected by RIA in all of these lysates, 
but not in lysates of non-B cell lines examined previously (24).  The ALL null 
and pre-B cells differed from PWM-stimulated lymphocytes from PB of normal 
individuals with  respect to  the amount and  molecular form of intracellular J 
chain. Although 21-88%  of null and pre-B cells contained J  chain identifiable 
by  immunoelectron microscopy, only  8.8-34.5  ng J  chain  per  107  cells  was 
measured by RIA.  By comparison, 6%  of unstimulated lymphocytes from PB 
displayed J  chain  and  this  sample  contained  6.6  ng/107  cells.  After  PWM 
stimulation,  57%  of the  cells  were  positive  for J  chain  by  immunoelectron 
microscopy on day 8, and the amount of intracellular J  chain increased to  128 
ng/107 cells. These values indicate that in null, pre-B, and B cells, the J  chain 
levels are considerably lower than those present in PWM-stimulated PBL. 
We have shown previously that reduction and alkylation results in: (a) mark- 
edly increased intensity of intracellular immunofluorescence  of cells stained with 
fluorochrome-labeled anti-J  chain (11);  (b)  exposure of originally inaccessible 
antigenic determinants of  J chain in polymeric myeloma IgA, secretory IgA, and 
IgM (26); and (c) detectability by RIA of intracellular J chain in lysates of human FIGURE 3.  Subcellular distribution of# chain in leukemic pre-B cells. (A) A  single # chain- 
positive pre-B cell from PB exhibits the positivity on free ribosomes. × 8,500. (B) A large pre- 
B cell from BM contains ribosomal clusters that are #  chain positive.  ×  10,200. (C) A  large 
pre-B cell from leukemic cell line 697 during mitotic division. The positivity for #  chain is 
expressed within long tubules of RER, (c-chromatin material). ×  11,200. (D) Detail of a pre- 
B cell from leukemic cell line 207. The two short tubules of RER containing # chain are in 
close apposition  to  the cell  surface,  one  of them  merging with cell  membrane (arrow).  × 
26,500. (E) The vesicles in the Golgi region ofa pre-B leukemic cell line 207 contain # chain. 
×  17,100. 
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TABLE II 
Expression of  J  Chain and # Chain by Normal PBL Before and After Stimulation with PWM 
Culture in- 
terval in 
days 
Intracellular J  chain  Intracellular ~t chain 
(EM)*  (EM)*  Amounts of  J  chain (ng/107 cells) 
Percent  Positive cell  Percent  Positive cell  Intracellular  Secreted 
positive  type*  positive 
cells  cells  type*  Total  0  Free  Total  0  Free 
0  6  L (100)  o  1  L (100)  6.6  1.6  ND  ND 
2  34  L,LB (100)  5  L,LB (100)  ND  ND  ND  ND 
5  49  LB (95)  9  LB (12)  35.0  15.0  65.0  0 
PC (5)  PC (88) 
8  57  LB (95)  11  LB (6)  128.0  73.0  280.5  0 
PC(5)  PC(94) 
* Electron microscopy. 
Total J  chain content was measured after the reduction and alkylation of cell lysates or culture 
supernatants; free J  chain was measured in unreduced samples of these fluids. 
* L, lymphocytes; LB, lymphoblasts; PC, immature and mature plasma~cells. Numbers in parentheses 
indicate the relative ,distribution of the cell types that express intracellular J or/~ chains. 
lymphoblastoid cell lines that secrete polymeric IgM or IgA (24).  Therefore, J 
chain was measured in lysates of cells listed in Tables I and II before and after 
reduction and alkylation to determine whether the cleavage of disulfide bonds 
would  affect  the  levels  of J  chain  measured  by  RIA.  Although  there  were 
variations in individual samples, it was apparent that in most of the null, pre-B, 
and  B  cells,  the  amount  of J  chain  detected after  reduction  and  alkylation 
exceeded that measured directly. This  was also true for unstimulated normal 
lymphocytes from  peripheral  blood.  After PWM  stimulation,  however,  more 
than half of the intracellular J  chain could be measured without reduction and 
alkylation  of the  samples  (Table  II).  In  contrast, J  chain  present  in  culture 
supernatants  of PWM-stimulated  PBL  became  detectable by  RIA  only after 
reduction and alkylation. These findings are in  agreement with our previous 
studies (24) in which we determined that such cells do not secrete J  chain unless 
it is associated with polymeric IgA or IgM. 
Discussion 
Results of this  study indicate that J  chain  is detectable by immunoelectron 
microscopy and RIA in human lymphoid cells that represent the earliest recog- 
nizable developmental stages along the B cell axis. J  chain was found in HLA- 
DR  + null leukemia cells, pre-B leukemia cells, normal B cells, and immature as 
well as  mature plasma cells.  These observations  confirm the earlier study of 
McCune et al. (17) and indicate that J chain is expressed in precursors of human 
B cells. The failure to detect J  chain in such cells by immunofluorescence (4), as 
opposed  to  in  vivo pulse  labeling,  in  vitro  translation  of total  cellular RNA, 
immunoelectron microscopy, and RIA, may reflect differences in sensitivities of 
these techniques. Furthermore, antigenic determinants of intracellular J  chain 
may be masked by association with immunoglobulins or with unidentified cell 
components. Detection of increased numbers of J  chain-positive cells and the 
increased intensity of staining after incubation with acid-urea (3, 37), reduction FIGURE 4.  Subcellular distribution of  J  chain in PWM-stimulated PBL. (A) A small lympho- 
cyte on the 2rid d of culture is positive for J  chain on free ribosomes. The Golgi apparatus 
near the nuclear indentation is negative.  ×  13,700.  (B) A  lymphoblast from the 2nd d  of 
culture  contains J  chain  on  non-membrane-associated  ribosomes  and  ribosomal  clusters 
distributed throughout the cytoplasm.  ×  8,500. (C) Lymphoblastoid cell on day 5 in culture 
contains J  chain on free ribosomes and ribosomal clusters, whereas the Golgi apparatus and 
RER are negative. ×  8,400. (D) A mature plasma cell on day 8 of culture. J  chain is localized 
in a  well-developed RER system,  x  13,100.  (E)  Detail of the Golgi apparatus of a  mature 
plasma cell on day 8 in culture withJ chain-positive tubules and vesicles. ×  24,000. 
2001 FIGURE 5.  Subcellular distribution of ~t chain in PWM-stimulated PBL.  (A) An immature 
plasma  cell  from  5-d  culture.  Mu  chain  is present  in  long narrow  tubules of the  RER.  × 
14,600.  (B) A  mature plasma cell on day 8  culture contains tt chain both in widened RER 
tubules and  in  the  Golgi  apparatus (g).  ×  10,800.  (C)  On  day  8  in  culture,  the  tt  chain- 
containing RER channels are wide and distended up to the cisternae in many of the plasma 
cells. ×  24,000. (D) From day 5 in culture, many of the plasma cells contain # chain in RER 
tubules and in the Golgi apparatus. ×  15,100. 
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and  alkylation  (11),  or  mild pretreatment  of tissue  sections with  trypsin  (38) 
support this contention.  Such treatment is particularly  effective in exposing J 
chain determinants in B cell blasts. For example, Brandtzaeg (37) observed that 
exposure of unstimulated human PBL to acid-urea  reduced the numbers of J 
chain-negative IgA blasts  from  21-50%  to  3-13%.  In the null leukemia cells 
that we examined, J  chain was apparently bound to nonimmunoglobulin cellular 
components since  the immunogiobulin gene rearrangements  in such cells are 
nonproductive (30).  With  respect  to intracellular distribution, J  chain was de- 
tected by immunoelectron microscopy in null and pre-B cells on free ribosomes 
and ribosomal clusters, and on perinuclear cisterna-bound ribosomes, but not in 
the  Golgi  apparatus.  In  PWM-stimulated  PBL, J  chain  was  found  on  non- 
membrane-associated ribosomes in lymphoid cells, whereas in plasma cells it was 
detected within RER and rarely in the Golgi region. Our results are in agreement 
with those of Nagura et al. (39) who described a similar distribution of J  chain 
in unstimulated lymphocytes and in plasma cells from rectal biopsies. In contrast, 
# chain was detected in association with ribosomes within PWM-induced lympho- 
blasts, and in RER and the Golgi apparatus of plasma cells. Dissimilarity in the 
subcellular  distributions  of #  and J  chains  may  be  related  to  differences  in 
intracellular  kinetics  and  mechanisms  of  secretion.  J  chain  has  never  been 
detected in supernatants of cultured lymphoid cells unless attached to polymeric 
immunogiobulins (13,  24)  and  is  degraded  in  cells  that  produce  monomeric 
immunoglobulins (40). 
The presence of mRNA as well as translatedJ chain in cells that do not produce 
immunogiobulins (15,  17, this paper) indicates that expression of these proteins 
can be independently regulated during differentiation of cells along the human 
B cell pathway. Recently, Yagi et al. (41) have shown that a  single J  chain gene 
per haploid genome is located on  mouse chromosome 5  and is not  linked to 
immunoglobulin heavy and light chain structural genes. A functional advantage 
for the expression of J  chain, before expression of # chain in B cell precursors, 
is not immediately evident, but cannot be related to immunogiobulin polymeri- 
zation. 
These results are at variance with the proposal thatJ chain synthesis is initiated 
during the  differentiation  of B  cells  into  immunoglobulin-secreting cells as  a 
consequence of mitogenic or antigenic stimulation (3,  16,  42).  Because  the J 
chain-positive null and pre-B leukemia cells lack cell surface immunoglobulins, 
and probably receptors for mitogens and T  cell factors as well, J chain expression 
would  appear  to  precede  the  antigen-induced  series  of events  that  leads  to 
maturation  into  immunoglobulin-producing cells.  Nevertheless,  a  remarkable 
increase in synthesis of  J chain in mitogen-stimulated cells parallels the production 
of  immunoglobulins,  regardless  of  their  class  (14,  24).  J  chain  synthesis  is 
preserved in both normal and malignant cells that produce monomeric immu- 
noglobulins, or only heavy or light chains (4,  9-15,  24,  42).  Once initiated, J 
chain expression in cells of B lineage apparently persists even in mature plasma 
cells secreting immunoglobulin molecules devoid of  J chain. For example, PWM- 
induced, IgG-producing cells expressed J  chain as did plasma cells that produced 
IgM  or  IgA.  While J  chain  could participate,  in collaboration  with  disulfide- 
interchange enzymes (43, 44), in the formation of intra- or inter-chain disulfide 2004  EXPRESSION OF # ANDJ CHAIN IN B CELL DIFFERENTIATION 
bonds of heavy and light chains, any additional role(s) remains to be determined. 
The  expression  of J  chain  in  lymphoid cells that  do not produce polymeric 
immunoglobulins  could  be  attributed  to  malignant  transformation.  However, 
malignant cells of myeloid or T  cell lineages did not contain detectable J  chain. 
Furthermore,  the presence of intracytoplasmic J  chain in resting B lymphocytes 
and  in  nonmalignant  cells that  produce monomeric  immunoglobulins  is  more 
consistent  with  the  view  that  early J  chain  synthesis  is  the  rule  for  B  cell 
differentiation in humans. 
Summhry 
J  chain expression was examined as a  function of the stage in differentiation 
along the  B cell axis in humans.  Intracellular  distribution  of J  and #  chains in 
leukemic HLA-DR  + null and pre-B cells, and in normal  B cells stimulated with 
pokeweed mitogen (PWM) was determined by immunoelectron microscopy and 
radioimmunoassay (RIA). J  chain was detected in leukemic null and pre-B cells 
on  free  and  membrane-bound  ribosomes in  the  cytoplasm,  or on  perinuclear 
cisternae.  Mu  chain  was  found  on  free  ribosomes  and  ribosomal  clusters  in 
leukemic pre-B cells but was absent in the leukemic null cells. In pre-B cell lines, 
#  chain  was  seen  within  rough  endoplasmic  reticulum  (RER)  and  the  Golgi 
apparatus whereas J  chain was not detected in these organelles.  However, both 
# and J  chain were detected in RER and the Golgi apparatus of immature and 
mature  plasma cells induced  by PWM stimulation  of normal  peripheral  blood 
lymphocytes.  Low  levels  of J  chain  were  also  detected  by  RIA  in  lysates  of 
leukemic null and pre-B cells. Most of the intracellular J chain became detectable 
after reduction and alkylation of cell lysates, and free J  chain was not found in 
the culture supernatants. The amount of intracellular and secreted immunoglob- 
ulin-bound J  chain increased dramatically after PWM stimulation  of peripheral 
blood lymphocytes. The majority of  J chain-positive cells seen over an 8 d culture 
interval were lymphocytes and lymphoblasts, while # chain was found primarily 
in plasma cells. These results suggest that J  chain  expression precedes t~ chain 
synthesis during B cell differentiation and that a combination of the two chains 
for secretion is not initiated until the onset of plasma cells maturation. 
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